Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis

Shankar Tumati*, Sander Martens, Andreas Aleman

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

58 Citations (Scopus)

Abstract

Research using proton magnetic resonance spectroscopy (MRS) can potentially elucidate metabolite changes representing early degeneration in Mild Cognitive Impairment (MCI), an early stage of dementia. We integrated the published literature using meta-analysis to identify patterns of metabolite changes in MCI. 29 MRS studies (with a total of 607 MCI patients and 862 healthy controls) were classified according to brain regions. Hedges' g was used as effect size in a random effects model. N-Acetyl Aspartate (NAA) measures were consistently reduced in posterior cingulate (PC), hippocampus, and the paratrigonal white matter (PWM). Creatine (Cr) concentration was reduced in the hippocampus and PWM. Choline (Cho) concentration was reduced in the hippocampus while Cho/Cr ratio was raised in the PC. Myo-inositol (mI) concentration was raised in the PC and mI/Cr ratio was raised in the hippocampus. NAA/mI ratio was reduced in the PC. NAA may be the most reliable marker of brain dysfunction in MCI though mI, Cho, and Cr may also contribute towards this. (C) 2013 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)2571-2586
Number of pages16
JournalNeuroscience and Biobehavioral Reviews
Volume37
Issue number10
DOIs
Publication statusPublished - Dec-2013

Keywords

  • Mild Cognitive Impairment (MCI)
  • Alzheimer's Disease (AD)
  • Magnetic Resonance Spectroscopy (MRS)
  • N-Acetyl Aspartate (NAA)
  • Choline (Cho)
  • Creatine (Cr)
  • Myo-inositol (mI)
  • Posterior cingulate
  • Hippocampus
  • Paratrigonal white matter
  • PROTON MR-SPECTROSCOPY
  • POSTERIOR CINGULATE GYRI
  • ALZHEIMERS-DISEASE
  • N-ACETYLASPARTATE
  • IN-VIVO
  • H-1 MRS
  • METABOLIC-CHANGES
  • HUMAN BRAIN
  • ABSOLUTE QUANTIFICATION
  • HIPPOCAMPAL METABOLITES

Cite this